

Current recommendation is to administer #boosters preferably after 6⃣ months. Available data support safe and effective administration of a booster dose as early as 3⃣ months from completion of primary vaccination. #EMAPresser
— EU Medicines Agency (@EMA_News) December 9, 2021
Pfizer/BioNTech #COVID19vaccines in children aged 5-11 years: Safety data are reassuring. So far, no safety concerns have emerged from large vaccination campaigns in this group in the 🇺🇸. #EMAPresser
— EU Medicines Agency (@EMA_News) December 9, 2021